The required information typically includes: Diagnosis: Documentation of the patients condition, such as type 2 diabetes, obesity, hypertension, or cardiovascular issues, that warrants the use of a GLP-1 medication
Recent studies have shown that GLP-1 use is associated with a reduction in cases of dementia among people with type 2 diabetes (something that's likely to also be true in a broader population of people at risk for dementia)
Color-coded tape or different label styles help prevent mix-ups during early morning or late evening dosing when attention may be lower
Major dietary sources include animal products like meat, seafood, eggs, nuts, and dairy products (including low-fat dairy)
Both have a long history of use as dietary supplements